Trust the (cell manufacturing) process: Turning Research into ATMP in Flemingsberg!
Are you a practicing scientist from academia and/or industry, or simply interested in advanced therapies? We at the Flemingsberg Science Foundation warmly welcome you to the most important ATMP event of the spring!
When? March 21st
Where? Svartsjön room, Novum building, Campus Flemingsberg
Hälsovägen 7, 141 57 Huddinge
Stories of patients with long term durable responses to cell and gene therapies make headlines in the media and bring hope to patients in need of treatment options. However, getting new Advanced Therapy Medicinal Products (ATMPs) from the research lab to the reality of the patient bedside, relies not only on a robust and scalable cell manufacturing process, but also on successful navigation of the regulatory environment and an engaged and supportive ATMP community.
As stakeholders with a shared vision of creating momentum in accelerating access to ATMPs in the Nordics, Flemingsberg Science Foundation, Karolinska ATMP-centrum and Miltenyi Biotec Nordics are proud to host an educational seminar aimed at highlighting challenges and opportunities in getting new ATMPs from concept to clinic. Join Nordic cell therapy experts and enthusiasts in uniting towards bringing more ATMP options to more patients, more efficiently.
Welcome!
Speakers:
Johnny Högberg
Matti Sallberg
Pontus Blomberg
Stephan Mielke
Gustaf Ahlén
Di Yu
Stina Wickström
Nikola Vojnovic
Register here
Partners
Karolinska Universitetssjukhuset
Karolinska Institutet
Miltenyi Biotec
Elicera Therapeutics AB
ATMP Sweden
Martin Jönsson: ”Tiden är mogen för ett genombrott inom demensbehandling”
Närmare 100 000 svenskar lider av Alzheimers sjukdom. Globalt tros cirka 30 miljoner människor ha sjukdomen. I dag finns ingen bot men forskningen närmar sig en punkt där nya läkemedel kan få en avgörande betydelse. AlzeCure finns bland de läkemedelsbolagen som nått längst.
